1178 related articles for article (PubMed ID: 19569253)
1. New antimicrobial agents for the treatment of bacterial infections in cancer patients.
Rolston KV
Hematol Oncol; 2009 Sep; 27(3):107-14. PubMed ID: 19569253
[TBL] [Abstract][Full Text] [Related]
2. The use of new and better antibiotics for bacterial infections in patients with leukemia.
Rolston KV
Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S357-63. PubMed ID: 19778864
[TBL] [Abstract][Full Text] [Related]
3. Rational approach to limiting emergence of antimicrobial drug resistance.
Mbori-Ngacha DA
East Afr Med J; 1997 Mar; 74(3):187-9. PubMed ID: 9185420
[TBL] [Abstract][Full Text] [Related]
4. Clinical impact and relevance of antibiotic resistance.
French GL
Adv Drug Deliv Rev; 2005 Jul; 57(10):1514-27. PubMed ID: 15978698
[TBL] [Abstract][Full Text] [Related]
5. Economics of antibiotic resistance.
Sipahi OR
Expert Rev Anti Infect Ther; 2008 Aug; 6(4):523-39. PubMed ID: 18662118
[TBL] [Abstract][Full Text] [Related]
6. Reducing antimicrobial resistance through appropriate antibiotic usage in Singapore.
Hsu LY; Kwa AL; Lye DC; Chlebicki MP; Tan TY; Ling ML; Wong SY; Goh LG
Singapore Med J; 2008 Oct; 49(10):749-55. PubMed ID: 18946605
[TBL] [Abstract][Full Text] [Related]
7. What's new on the antimicrobial horizon?
Song JH
Int J Antimicrob Agents; 2008 Dec; 32 Suppl 4():S207-13. PubMed ID: 19134521
[TBL] [Abstract][Full Text] [Related]
8. Appropriate antibiotic use and why it is important: the challenges of bacterial resistance.
Lieberman JM
Pediatr Infect Dis J; 2003 Dec; 22(12):1143-51. PubMed ID: 14688589
[TBL] [Abstract][Full Text] [Related]
9. Preventing bacterial resistance in surgical patients.
Evans HL; Sawyer RG
Surg Clin North Am; 2009 Apr; 89(2):501-19, x. PubMed ID: 19281897
[TBL] [Abstract][Full Text] [Related]
10. Resistance to antibiotics: are we in the post-antibiotic era?
Alanis AJ
Arch Med Res; 2005; 36(6):697-705. PubMed ID: 16216651
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial stewardship: concepts and strategies in the 21st century.
Owens RC
Diagn Microbiol Infect Dis; 2008 May; 61(1):110-28. PubMed ID: 18384997
[TBL] [Abstract][Full Text] [Related]
12. Advances in antibacterial therapy against emerging bacterial pathogens.
Pournaras S; Iosifidis E; Roilides E
Semin Hematol; 2009 Jul; 46(3):198-211. PubMed ID: 19549574
[TBL] [Abstract][Full Text] [Related]
13. Bacterial targets to antimicrobial leads and development candidates.
Rogers BL
Curr Opin Drug Discov Devel; 2004 Mar; 7(2):211-22. PubMed ID: 15603255
[TBL] [Abstract][Full Text] [Related]
14. Outcome of infections caused by multiple drug-resistant bacteria in liver transplant recipients.
Gouvêa EF; Branco RC; Monteiro RC; Halpern M; Ribeiro-Filho J; Silveira VG; Tavares GC; Rodrigues MS; Coelho HS; Basto ST; Santoro-Lopes G
Transplant Proc; 2004 May; 36(4):958-60. PubMed ID: 15194333
[TBL] [Abstract][Full Text] [Related]
15. The challenge of antibiotic resistant bacterial pathogens: the medical need, the market and prospects for new antimicrobial agents.
Payne D; Tomasz A
Curr Opin Microbiol; 2004 Oct; 7(5):435-8. PubMed ID: 15451496
[No Abstract] [Full Text] [Related]
16. Optimizing antimicrobial prescribing.
Isturiz RE
Int J Antimicrob Agents; 2010 Nov; 36 Suppl 3():S19-22. PubMed ID: 21129628
[TBL] [Abstract][Full Text] [Related]
17. Management of the febrile neutropenic patient.
Picazo JJ;
Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S120-2; discussion S133-40. PubMed ID: 16243492
[TBL] [Abstract][Full Text] [Related]
18. New developments in carbapenems.
Kattan JN; Villegas MV; Quinn JP
Clin Microbiol Infect; 2008 Dec; 14(12):1102-11. PubMed ID: 19076841
[TBL] [Abstract][Full Text] [Related]
19. The need for new antibiotics.
Livermore DM
Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():1-9. PubMed ID: 15522034
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial resistance: mechanisms and strategies.
Woods CR
Paediatr Respir Rev; 2006; 7 Suppl 1():S128-9. PubMed ID: 16798537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
